Journal of Cellular & Molecular Anesthesia

Manuscripts submitted to the Journal of Cellular and Molecular Anesthesia should be prepared according to guidelines established by the International Committee of Medical Journal Editors (see 'Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication' available at: http://www.icmje.org/) as well as the following instructions.

Any questions concerning manuscript submission should be directed to:

Ali Dabbagh, MD, Professor of Cardiac Anesthesia; Anesthesiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Editor-in-Chief, Journal of Cellular and Molecular Anesthesia

alidabbagh@sbmu.ac.ir

Manuscript submission is only electronically (following the online process), and accompanied by a cover letter indicating that the object, totally or partly, has not been previously published and is not currently under consideration for publication in another journal. All files submitted should be in an MS Word processed format, Microsoft Word 2010 or earlier. 

Ethical Considerations:

Submissions containing copies or self-plagiarism will be rejected. Authors are encouraged to carefully proofread their manuscripts before submission. To prevent plagiarism and copyright violation, the use of software such as iThenticate is recommended.

Microsoft Word is the preferred text file format. Submitted files must be editable; do not submit pdf files of your text.

Authors Responsibilities

1. All authors must be:

• scientifically senior in the field of research
• accountable for the accurateness of the article
• able to certify that the manuscript is their original work and has not been previously published elsewhere; even simultaneous submissions being under review in another journal are prohibited
• accountable to all the data provided in the paper; these data should be authentic
• and responsible about their data and report any potential or possible errors being discovered in the manuscript before submission, during assessment and, after acceptance or publishment of their paper to the journal editors

• although it is the responsibility of the corresponding author to complete the correspondence in the requested timeline, all authors must actively participate in the peer review process and participate actively and responsibly in formulating responses to the views raised by the peer reviewers.

• this journal does not charge authors for the submission or publication of manuscripts

2. All potential and factual conflicts of interest relating to the manuscript content, preparation, and financial support must be declared. The authors have to inform the Editors of any conflicts of interest.
3. Authors presenting work involving human experimentation must:

• comply with Good Clinical Practice guidelines (http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf)  as outlined by the International Conference on Harmonization (http://www.ich.org)
• provide evidence of informed consent specific to the investigation where required
• affirm at the beginning of the Methods section that the study has been reviewed and approved by an Investigational Review Board (IRB)

4. Authors presenting work involving animal experimentation must affirm in the Methods section that the study has been approved by an Animal Care Committee (IACUC) (http://www.iacuc.org).
5. The investigators are encouraged to register their clinical trials in ClinicalTrials.gov run by the National Library of Medicine (http://www.clinicaltrials.gov/) or other public submitting or publishing International Standard Randomized Controlled Trial Number (ISRCTN) (http://www.controlled-trials.com/isrctn/) or Iranian Registry Clinical Trials (IRCT) (http://www.irct.ir). The service is available at no charge. Also, this journal does not charge authors for the submission or publication of manuscripts. To be considered for publication, randomized, controlled trials involving medical interventions should be fully registered in one of the public trial registries before the conscription of the first patient. Well-controlled researches, including studies with negative results, are confident, more than ever.
   Where appropriate, CONSORT (http://www.consort-statement.org) or if analytic research is being reported, STARD (http://www.consort-statement.org/Initiatives/newstard.htm), and diagrams must be included. Observational Studies should meet the STROBE guiding principles (Strengthening the Reporting of Observational Studies in Epidemiology; http://www.strobe-statement.org/). Figures illustrating the appropriate diagram are requisite to be presented.
6. The text should be clearly "plagiarism-free"; i.e., the authors should not reproduce verbatim the text of previously published articles or manuscripts submitted in other texts; even if a text by the same author has already been officially published.

7. In each manuscript, all the authors of the article must have active, significant, and specific participation in conducting research and then in writing and editing the manuscript; this process should be based on the standard patterns of text writing and following the standards of the journal.

Author Substance Archive Strategy

Please note that except for special circumstances, JMCA will organize the whole electronic materials, two months after publication. If you require the return of any material submitted, please inform the Editorial Office or Production Editor as soon as possible if you have not already done so.

JCMA is currently indexed in Scopus, Embase, DOAJ, ISC, Google Scholar, NLM Catalog, and ROAD.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.